SynSense Completes Several-Hundred-Million-RMB Series B Financing Led by National-Level Fund

On June 30, 2026, SynSense, a globally leading provider of neuromorphic intelligent chips and solutions, today announced that it has successfully completed a Series B financing round of several hundred million RMB in June 2026. This round was jointly led by Guodiao Phase II Collaborative Development Fund Co., Ltd. and Sealand Securities, with follow-on participation from prominent financial investors including HTHS Capital, Huacang Capital, Nanling Fund, and Heshunying, as well as Honglida, which brings industrial synergy capabilities.

The successful completion of this financing round marks the strong recognition from both national-level capital and industrial capital of SynSense's foundational neuromorphic intelligence technologies and commercial prospects. The proceeds will be primarily used to accelerate the research and development and mass production preparation of full-stack brain-computer interface products based on neuromorphic intelligence, while also deepening the large-scale application and deployment of neuromorphic intelligent vision and sensing-computing technologies in core scenarios including consumer electronics, unmanned aerial vehicles, robotics, and high-end industrial vision.

As a national-level equity investment fund, the joint lead investor Guodiao Phase II Collaborative Development Fund is tasked with deploying strategic emerging industries and cultivating core sectors of "new quality productive forces." Its lead investment in SynSense precisely targets the strategic value of two key application areas of neuromorphic intelligence:

First, full-chain independence in the upstream brain-computer interface sector. SynSense is one of the few domestic companies with full-stack capabilities encompassing "electrodes, encoding and decoding chips, front-end acquisition modules, and complete device solutions," capable of filling the gap for domestic alternatives in research and medical-grade invasive brain-computer interfaces, aligning with the national strategic layout for bioeconomy and smart healthcare.

Second, a transformative leap in intelligent vision and sensing-computing technologies. Its next-generation neuromorphic fusion vision chip Aeveon™ moves beyond the conventional hardware stacking approach of traditional intelligent vision, redefining the CMOS image sensor paradigm through architectural innovation. It is broadly adaptable to industrial upgrading needs in consumer electronics, low-altitude economy, and high-end industrial inspection, representing a key technological domain for cultivating new growth drivers and supporting future competitive advantages in green, low-carbon, and high-end manufacturing.

The joint lead investor Sealand Securities, with deep expertise in hard technology industries and capital market resources, will synergize with the strategic endorsement of Guodiao Phase II Collaborative Development Fund to jointly support SynSense in refining its supply chain arrangements and accelerating commercial deployment.

Driven by the surging global demand for edge intelligence and the maturation of neuromorphic technologies, SynSense has experienced exponential growth in its business performance in recent years, with a compound annual growth rate exceeding 160% over the past two years. This robust growth trajectory marks the company's effective transition from technology research and development to mass production and delivery, and from benchmark case studies to scalable replication.

As a key practitioner advancing neuromorphic intelligence from cutting-edge research to industrial deployment, SynSense, with the backing of national-level capital, will continue to deepen its foundational neuromorphic technologies, accelerate the transition of its full-stack products from benchmark validation to large-scale deployment, and provide independently controllable Chinese solutions for global artificial intelligence development, helping the nation secure a leading position in the global competition of neuromorphic intelligence.